Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Leukemia

Free Subscription 09.02.2026 1 Am J Hematol 5 Ann Hematol 1 Blood 1 BMC Cancer 1 Cancer 1 Eur J Haematol 1 J Clin Oncol 4 Leuk Lymphoma 2 Leuk Res 2 Leukemia 1 PLoS Med 2 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Hematol

1. DENDORFER SM, Schmidt-Brucken K, Kramer M, Steffen B, et al
   Randomized Comparison of Cardiotoxicity With 60 Versus 90 mg Daunorubicin in AML Induction Therapy.
   Am J Hematol. 2026;101:512-520.
   PubMed         Abstract available
   
   

   
   Ann Hematol

2. YOON JH, Lee JH, Yang DH, Cheong JW, et al
   Real-world outcomes of inotuzumab ozogamicin treatment for adult relapsed or refractory acute lymphoblastic leukemia: a result from Korea post-marketing surveillance.
   Ann Hematol. 2026;105:91.
   PubMed        
   
   
3. GEORGI JA, Rollig C, Schetelig J, Thiede C, et al
   Relapse following FLT3 inhibitor cessation in FLT3-ITD-positive AML: lessons from two clinical cases.
   Ann Hematol. 2026;105:82.
   PubMed         Abstract available
   
   
4. GEISSLER K, Mitterbauer-Hohendanner G, Jager R
   Molecular devolution in chronic myelomonocytic leukemia during treatment with decitabine/cedazuridine: A case report.
   Ann Hematol. 2026;105:78.
   PubMed         Abstract available
   
   
5. SUAREZ EU, Atencia CJ, Torres-Saavedra FA, Conejero N, et al
   The effects of the PHF6 gene mutation on myeloid neoplasms. A single-center cohort underpinned by a systematic review of literature.
   Ann Hematol. 2026;105:77.
   PubMed         Abstract available
   
   
6. LU L, Liang Q, Yan Y, Tang Y, et al
   Dynamic changes in mortality risk factors for acute leukemia patients in the ICU and Post-ICU periods.
   Ann Hematol. 2026;105:76.
   PubMed         Abstract available
   
   

   
   Blood

7. TURKALJ S, Radtke FA, Stoilova B, Mecklenbrauck R, et al
   Rapid clonal selection within early hematopoietic cell compartments presages the outcome of ivosidenib combination therapy.
   Blood. 2026;147:613-632.
   PubMed         Abstract available
   
   

   
   BMC Cancer

8. NYEKO R, Kruger M, Niyonzima N, Atwiine B, et al
   Treatment outcomes and prognostic factors in children diagnosed with acute myeloid leukaemia in Uganda.
   BMC Cancer. 2025;26:159.
   PubMed         Abstract available
   
   

   
   Cancer

9. 
   Correction to "Risk scores predicting disease progression in early-stage chronic lymphocytic leukemia: comparative analysis and usefulness of IGHV subset #2 to improve their accuracy".
   Cancer. 2026;132:e70302.
   PubMed        
   
   

   
   Eur J Haematol

10. SABBAGH C
    Distribution of ABO/Rh Blood Types Across Childhood Leukemia Subtypes: A Retrospective Cohort Study of 540 Pediatric Patients.
    Eur J Haematol. 2026 Jan 30. doi: 10.1111/ejh.70127.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

11. VIEIRA MARTINS M, de Lorenzo P, Kotecha RS, Attarbaschi A, et al
    Sustained Benefit of Blinatumomab in Infants With KMT2A-Rearranged ALL: Long-Term Outcomes, Toxicity, and Pharmacokinetics.
    J Clin Oncol. 2026;44:370-374.
    PubMed         Abstract available
    
    

    
    Leuk Lymphoma

12. HERSTEIN JE, Marx KR, Haddad FG, Chien KS, et al
    Case series: rhabdomyolysis in patients taking isocitrate dehydrogenase inhibitors for myelodysplastic syndrome and relapsed/refractory acute myeloid leukemia.
    Leuk Lymphoma. 2026 Feb 2:1-3. doi: 10.1080/10428194.2026.2621831.
    PubMed        
    
    
13. YOSHIDA K, Mushino T, Tanaka K, Kosako H, et al
    Distribution of CD30-positive tumor cell proportions in adult T-cell leukemia/lymphoma.
    Leuk Lymphoma. 2026 Feb 3:1-5. doi: 10.1080/10428194.2026.2622526.
    PubMed        
    
    
14. O'BRIEN J, Tomlinson B, Patel MJ, Van Besien K, et al
    ATRA treatment in the emergency department is associated with reduced early mortality in acute promyelocytic leukemia-a real-world multicenter retrospective cohort analysis.
    Leuk Lymphoma. 2026 Feb 3:1-9. doi: 10.1080/10428194.2026.2623196.
    PubMed         Abstract available
    
    
15. TAN KW, Xu Y, Huang YH, Qiu QC, et al
    Coexistence of BCR::ABL1 with IKZF1::ETV6 fusion in an adult patient with acute B-lymphoblastic leukemia.
    Leuk Lymphoma. 2026 Feb 3:1-5. doi: 10.1080/10428194.2026.2621828.
    PubMed        
    
    

    
    Leuk Res

16. MIYASHITA A, Basendwah AM, Fero H, Alabbas F, et al
    CPX-351 versus venetoclax plus hypomethylating agents for newly diagnosed acute myeloid leukemia: A systematic review and meta-analysis.
    Leuk Res. 2026;162:108179.
    PubMed         Abstract available
    
    
17. BILANISHVILI A, Tsertsvadze T, Edwards K, John-Olabode S, et al
    The effect of IL-4 on CD180 expression and signalling in Chronic lymphocytic leukaemia (CLL).
    Leuk Res. 2026;161:108166.
    PubMed         Abstract available
    
    

    
    Leukemia

18. BIRDWELL CE, Fiskus W, Mill CP, Kadia TM, et al
    BET inhibitor-based combinations targeting novel dependencies in MECOM-rearranged (r) AML.
    Leukemia. 2026;40:304-313.
    PubMed         Abstract available
    
    
19. FULLIN J, Topcu E, Zielinska KA, Schimmer RR, et al
    The pathogenesis of therapy-related myeloid neoplasms from TP53-mutant clonal hematopoiesis.
    Leukemia. 2026;40:279-292.
    PubMed         Abstract available
    
    

    
    PLoS Med

20. HEMMINGSEN CH, Kjaer SK, Arvedsen J, Dahl EO, et al
    Leukemia in users of contemporary hormonal contraception: A nationwide registry-based cohort study among premenopausal women in Denmark.
    PLoS Med. 2026;23:e1004652.
    PubMed         Abstract available
    
    

    
    PLoS One

21. BEDOUI A, Ayadi W, Louati N, Frikha I, et al
    Genomic characterization and prognostic significance of copy number alterations in Tunisian patients with acute lymphoblastic leukemia.
    PLoS One. 2026;21:e0340696.
    PubMed         Abstract available
    
    
22. KAMIHARA Y, Kikuchi S, Ishikawa N, Shinomiya N, et al
    Antiapoptotic BCL2 family proteins BCL-XL and MCL1 as factors predicting resistance against venetoclax plus azacitidine for patients with newly diagnosed acute myelogenous leukemia.
    PLoS One. 2026;21:e0341461.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

23. QIAO N, Wang ZX, Zhang YL, Zhang LQ, et al
    HSCs/MPPs as cells of origin with altered differentiation hierarchy impairing immunomicroenvironment in PML::RARA and CBFalpha/beta fusion AML.
    Proc Natl Acad Sci U S A. 2026;123:e2526334123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum